Neoadjuvant endocrine therapy for resectable breast cancer: A systematic review and meta-analysis

Abstract Introduction The role of neoadjuvant endocrine therapy for resectable breast cancer is not well established, despite encouraging results obtained in the metastatic and adjuvant settings. This systematic review aims to examine existing medical literature on neoadjuvant hormone therapy (HT)....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast (Edinburgh) 2015-08, Vol.24 (4), p.406-412
Hauptverfasser:	Leal, Frederico, Liutti, Vitor Teixeira, Antunes dos Santos, Vivian Castro, Novis de Figueiredo, Maximiliano Augusto, Macedo, Ligia Traldi, Rinck Junior, José Augusto, Sasse, Andre Deeke
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents, Hormonal - therapeutic use Aromatase inhibitor Aromatase Inhibitors - therapeutic use Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - surgery Chemotherapy, Adjuvant - methods Endocrine therapy Female Hematology, Oncology and Palliative Medicine Humans Mastectomy, Segmental Neoadjuvant Preoperative Prospective Studies Randomized Controlled Trials as Topic Tamoxifen
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!